2 Stocks Down 45% and 37% to Buy Right Now

Lululemon shares are down ~45% year-over-year amid slowing North American demand, tariff pressure and a CEO transition, yet Q3 revenue rose 7% with Americas down 2% and international up 33% (China +46%, RoW +19%), net income of $306.8M, over $1B cash, zero long-term debt and a forward P/E near 15 versus a historical >30. Zebra Technologies is down ~37% Y/Y but reported Q3 revenue of $1.32B (+~5% YoY) with EVM contributing $865M and AIT $455M; management is pivoting into edge AI and AI-powered applications (e.g., Zebra Companion) with commercialization expected to begin in 2026 while exiting its AMR business. Both names are pitched as buy-the-dip opportunities based on durable fundamentals, international expansion (LULU) and an AI-driven software/hardware transition (ZBRA), but corporate governance changes, competition and execution risk counsel caution for allocators.

Analysis

Market structure: LULU’s pain is concentrated in North American discretionary spend while its international revenue (China +46% Q3, RoW +19%) and fortress balance sheet (>$1bn cash, zero LT debt) preserve pricing power and margins; suppliers of premium fabrics and tariff-exposed inputs are losers as margin leakage could widen ~100–300 bps if tariffs persist. ZBRA benefits from secular enterprise digitization and edge-AI upgrades; exiting AMR reallocates capital to higher-margin software/subscription mix, shifting share toward software-enabled hardware vendors and increasing recurring revenue share. Cross-asset: deeper LULU drawdowns would modestly increase consumer discretionary credit spreads and equity implied volatility (IV up 20–40% vs 30‑day), strengthen USD safe-haven flows short-term, and pressure cotton/textile commodity cyclical names if retail destocking persists.

Risk assessment: Tail risks include activist-driven asset sales or buybacks at suboptimal prices (LULU), a failed AI monetization or chip supply bottleneck at ZBRA delaying revenue beyond 2026, and macro consumer credit stress that knocks NA comps down >10% YoY. Time horizons: days — headline volatility around CEO/activist disclosures; weeks–months — Q4 comps, spring 2026 product refresh; 12–36 months — international expansion and ZBRA AI revenue realization. Hidden dependencies: LULU’s Chinese growth depends on local retail demand and FX; ZBRA’s edge-AI rollout hinges on semiconductor availability and pilot-to-contract conversion rates. Key catalysts: CEO appointment (30–90 days), activist filings, Q4 earnings, and ZBRA’s 2026 commercial AI rollouts.

Trade implications: Direct plays — opportunistic long LULU for patient capital (valuation down to ~15x forward P/E) and selective long ZBRA for 2026 AI monetization. Options — for ZBRA prefer 9–15 month call spreads to cap premium while keeping upside; for LULU consider selling covered calls after establishing position to harvest yield if IV normalizes. Pair trades — long LULU vs short broad retail (XRT) to isolate idiosyncratic recovery; long ZBRA vs short pure-play AMR/robotics peers to capture reallocation to software-enabled hardware. Entry/exit — scale into positions on confirmed sequential improvement (NA comps delta improving month-over-month or ZBRA pilot-to-contract conversions >10% of pilots) and trim on negative catalyst misses.

Contrarian angles: Consensus underprices LULU’s ROIC (~30%) and cash buffer that allow multi-year reinvestment; a 45% drawdown likely overstates permanent impairment risk. Market may be over-discounting LULU’s brand moat — a successful spring 2026 product refresh could trigger a >30% rebound from current levels if NA comps stabilize. For ZBRA, the market may underappreciate subscription leverage: if software grows to 20%+ of revenue by 2027, EBITDA margins could expand materially; unintended consequence — activist pressure at LULU could force short-term capital allocation choices that slow long-term international investment and cede share to rivals.

Key Decisions for Investors

• Establish a 2.5% long position in LULU within 2 weeks (buy on intraday weakness or in tranches); add to 5% total over 6–12 months if North American comps improve sequentially (less negative by ≥3 percentage points) or international revenue growth stays >25% YoY. Set a tactical stop-loss at -25% from entry or trim by 50% if quarterly gross margin falls >150 bps vs prior quarter.
• Initiate a 1.5–2% long position in ZBRA via a 12-month call spread (buy ATM call, sell 30–40% OTM call) to capture 2026 AI commercialization upside while capping cost. Increase to 4% if company guides AI-related ARR >5% of revenue for 2026; protect with 6-month 8–10% OTM puts sized to limit drawdown to ~10% of portfolio allocation.
• Implement a pair trade: Long LULU 2.5% vs Short XRT 2% (equal notional) to isolate idiosyncratic recovery in premium athleisure; rebalance after two consecutive quarters of NA comp improvement or after CEO announcement. Close the pair if XRT outperforms LULU by >15% over a 60-day window.
• Reduce broad consumer discretionary exposure by 3–5% over 30 days and redeploy proceeds into industrials/AI hardware exposure (e.g., ZBRA) and short-duration credit to hedge consumer cycle risk; re-evaluate allocation after next two earnings seasons or if consumer credit delinquencies rise >25% YoY.